Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”
Science & Tech
Editorial note: This article represents original analysis and commentary by the TechDailyPulse editorial team.